Skip to main content

Want a detailed portfolio tracker?

Biomea Fusion (BMEA) P/E (2021 - 2026)

Biomea Fusion (BMEA) P/E from Apr 16, 2021 to Jul 21, 2026. The TTM Biomea Fusion (BMEA) P/E is -1.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Biomea Fusion (BMEA)

YearP/EChange
2026-1.80+95.20%
2025-0.92-9.19%
2024-1.01-76.75%
2023-4.36+25.91%
2022-3.46-20.23%
2021-4.34N/A

Comparison Biomea Fusion (BMEA) P/E with competitors

Biomea Fusion (BMEA) P/E is -1.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.00-100.24%
ENLVEnlivex Ltd0.07-104.16%
FGENFibroGen Inc0.24-113.36%
CHRSCoherus Biosciences Inc0.85-147.24%
FBIOFortress Biotech Inc0.95-152.83%
ORMPOramed Pharmaceuticals Inc1.50-183.68%
AGENAgenus Inc3.01-267.55%
INVAInnoviva Inc3.15-275.59%
VXRTVaxart Inc3.55-297.62%
CRMDCorMedix Inc3.63-302.00%
CVACCureVac N.V.4.45-347.49%
GLPGGalapagos NV4.86-370.50%
SRPTSarepta Therapeutics Inc4.88-371.79%
ABEOAbeona Therapeutics Inc5.39-399.93%
ABUSArbutus Biopharma Corp5.60-411.51%
ZVRAZevra Therapeutics Inc5.89-427.75%
SPROSpero Therapeutics Inc6.23-446.74%
CGENCompugen Ltd6.31-451.50%
RIGLRigel Pharmaceuticals6.87-482.57%
SLXNSilexion Therapeutics Corp7.30-506.18%
OMEROmeros Corporation9.26-615.44%
AUPHAurinia Pharmaceuticals Inc9.58-633.60%
PLXProtalix BioTherapeutics Inc10.89-706.31%
ACADAcadia Pharmaceuticals Inc11.73-752.93%
TBPHTheravance Biopharma Inc12.26-782.64%
ADMAAdma Biologics Inc12.42-791.33%
HRMYHarmony Biosciences Holdings Inc13.82-869.38%
SABSSAB Biotherapeutics Inc14.14-886.97%
NAGENiagen Bioscience Inc14.82-924.94%
INCYIncyte Corp15.82-980.85%
REGNRegeneron Pharmaceuticals Inc15.86-982.75%
PBYIPuma Biotechnology Inc17.32-1063.98%
CPRXCatalyst Pharmaceuticals Inc17.44-1070.86%
EXELExelixis Inc17.54-1076.35%
TGTXTG Therapeutics Inc18.97-1155.85%
MDXGMimedx Group Inc20.55-1244.17%
XOMAXOMA Royalty Corp22.87-1373.49%
ARGXArgen X SE24.30-1452.72%
CTMXCytomX Therapeutics Inc24.82-1481.85%
XOMAOXOMA Royalty Corp25.34-1511.00%
HALOHalozyme Therapeutics Inc25.62-1526.53%
XOMAPXOMA Royalty Corp25.67-1529.11%
VRTXVertex Pharmaceuticals Inc27.99-1658.53%
RPRXRoyalty Pharma plc - Class A28.69-1697.10%
SLNOSoleno Therapeutics Inc29.02-1715.35%
ASNDAscendis Pharma A/S30.09-1774.93%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2210.65%
APLSApellis Pharmaceuticals Inc39.02-2272.40%
BMRNBiomarin Pharmaceutical Inc42.21-2450.03%
KRYSKrystal Biotech Inc45.34-2624.37%
ONCBeiGene Ltd69.54-3971.47%
PHARPharming Group N.V.75.03-4276.84%
TECHBio-Techne Corp101.96-5776.25%
VCELVericel Corp109.92-6219.57%
ALNYAlnylam Pharmaceuticals Inc117.96-6667.38%
GMABGenmab140.29-7910.31%
TLXTelix Pharmaceuticals Ltd162.15-9127.42%
CORTCorcept Therapeutics Inc212.86-11950.26%